Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Treatment with a novel topical nanoemulsion (NB-001) speeds time to healing of recurrent cold sores.

Kircik L, Jones TM, Jarratt M, Flack MR, Ijzerman M, Ciotti S, Sutcliffe J, Boivin G, Stanberry LR, Baker JR; NB-001 Study Group.

J Drugs Dermatol. 2012 Aug;11(8):970-7.

PMID:
22859243
2.

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.

Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ; PRECiSE 2 Study Investigators.

Am J Gastroenterol. 2010 Jul;105(7):1574-82. doi: 10.1038/ajg.2010.78. Epub 2010 Mar 16.

PMID:
20234346
3.

Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.

Lichtenstein GR, Thomsen OØ, Schreiber S, Lawrance IC, Hanauer SB, Bloomfield R, Sandborn WJ; Precise 3 Study Investigators.

Clin Gastroenterol Hepatol. 2010 Jul;8(7):600-9. doi: 10.1016/j.cgh.2010.01.014. Epub 2010 Feb 1.

PMID:
20117244
4.

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group.

Gastroenterology. 2008 Oct;135(4):1130-41. doi: 10.1053/j.gastro.2008.07.014. Epub 2008 Jul 17.

PMID:
18706417
5.

Early experience with retrievable inferior vena cava filters in high-risk trauma patients.

Hoff WS, Hoey BA, Wainwright GA, Reed JF, Ball DS, Ringold M, Grossman MD.

J Am Coll Surg. 2004 Dec;199(6):869-74.

PMID:
15555969
6.

External beam irradiation as an adjunctive treatment in failing dialysis shunts.

Cohen GS, Freeman H, Ringold MA, Putnam SG, Ball DS, Silverman C, Schulman G.

J Vasc Interv Radiol. 2000 Mar;11(3):321-6.

PMID:
10735426
7.

Supplemental Content

Loading ...
Support Center